Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Watchlist
Price: 490.28 USD -19.01% Market Closed
Market Cap: 52.9B USD

Wall Street
Price Targets

REGN Price Targets Summary
Regeneron Pharmaceuticals Inc

Wall Street analysts forecast REGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REGN is 824.33 USD with a low forecast of 540.35 USD and a high forecast of 1 063.65 USD.

Lowest
Price Target
540.35 USD
10% Upside
Average
Price Target
824.33 USD
68% Upside
Highest
Price Target
1 063.65 USD
117% Upside
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
KALV
Kalvista Pharmaceuticals Inc
133% Upside
688177
Bio-Thera Solutions Ltd
3% Downside
1952
Everest Medicines Ltd
20% Upside
TNGX
Tango Therapeutics Inc
382% Upside
GNFT
Genfit SA
141% Upside
STOK
Stoke Therapeutics Inc
150% Upside
7774
Japan Tissue Engineering Co Ltd
109% Upside

Revenue
Forecast

Revenue Estimate
Regeneron Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 5%.

14%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Regeneron Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's operating income is 16%. The projected CAGR for the next 3 years is 13%.

16%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Net Income
Forecast

Net Income Estimate
Regeneron Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's net income is 22%. The projected CAGR for the next 3 years is 7%.

22%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REGN's stock price target?
Price Target
824.33 USD

According to Wall Street analysts, the average 1-year price target for REGN is 824.33 USD with a low forecast of 540.35 USD and a high forecast of 1 063.65 USD.

What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is 5%.

What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's operating income is 16%. The projected CAGR for the next 3 years is 13%.

What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's net income is 22%. The projected CAGR for the next 3 years is 7%.

Back to Top